chronic inflammation

August 2, 2023

Personalizing treatment for sinus syndrome

Understanding the inflammatory characteristics of subtypes of chronic rhinosinusitis with polyps should assist with selection of effective therapies, Vanderbilt researchers report.

By Leigh MacMillan
C. Henrique Serezani, PhD, right, and colleagues, from left, Amondrea Blackman, Nathan Klopfenstein and Júlia Miranda Ribeiro Bazzano are studying the early events of the inflammatory response to infection.
December 10, 2020

Study details early events of inflammatory response

Vanderbilt University Medical Center investigators have identified a key molecular player in the early events of the inflammatory response to infection. The findings suggest new therapeutic possibilities for enhancing the inflammatory response to protect against pathogens and for blocking inflammation gone awry in diseases like arthritis and atherosclerosis.

By Leigh MacMillan
August 11, 2020

Risk marker for repeat sinus surgery

An inflammatory factor in mucus could be a biomarker of treatment-resistant chronic sinusitis used to determine which patients are at risk for repeat sinus surgery.

By Leigh MacMillan
March 22, 2016

New treatment for Crohn’s disease

A new biological therapy, ustekinumab, improves markers of disease activity in patients with severe Crohn’s disease.

By Leigh MacMillan
discarded clothing size tags
October 16, 2014

Lymphocyte study reveals obesity clues

Vanderbilt University researchers are closer to understanding the link between obesity, chronic inflammation and type 2 diabetes.

By Bill Snyder